✦ LIBER ✦

Potential of 5-aza-2′-deoxycytidine (Decitabine) a potent inhibitor of DNA methylation for therapy of advanced non-small cell lung cancer

✍ Scribed by Momparler, Richard L; Ayoub, J

Book ID: 118570703
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 89 KB
Volume: 34
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(01)00397-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

[Medical Intelligence Unit] DNA Methylat

[Medical Intelligence Unit] DNA Methylation and Cancer Therapy || Preclinical and Clinical Studies on 5-Aza-2′-Deoxycytidine, a Potent Inhibitor of DNA Methylation, in Cancer Therapy

✍ Momparler, Richard L. 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 872 KB

Dna Methylation : Three Decades In Search Of Function / Aharon Razin -- Epigenetic Mechanisms Of Gene Regulation : Relationships Between Dna Methylation, Histone Modification, And Chromatin Structure / Keith D. Robertson -- Dna Hypo- Vs. Hypermethylation In Cancer : Tumor Specificity, Tumor Progress

5-Azacytidine and 5-aza-2′-deoxycytidine

5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy

✍ Christman, Judith K 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 380 KB

DNA Methylation status of Wnt antagonist

DNA Methylation status of Wnt antagonistSFRP5can predict the response to the EGFR-tyrosine kinase inhibitor therapy in non-small cell lung cancer

✍ Jian Zhu, Yuyan Wang, Jianchun Duan, Hua Bai… 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 325 KB

5-Aza-2′-deoxycytidine is a potent inhib

5-Aza-2′-deoxycytidine is a potent inhibitor of DNA methyltransferase 3B and induces apoptosis in human endometrial cancer cell lines with the up-regulation of hMLH1

✍ Min Cui; Zeqing Wen; Ji Chen; Zhongli Yang; Hualing Zhang 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 462 KB

Phase I/II study of daily carboplatin, 5

Phase I/II study of daily carboplatin, 5-fluorouracil and concurrent radiation therapy for locally advanced non-small-cell lung cancer

✍ Yoshizawa, H; Tanaka, J; Kagamu, H; Maruyama, Y; Miyao, H; Ito, K; Sato, T; Iwas 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 95 KB

A prospective study of palliative hypofr

A prospective study of palliative hypofractionated radiation Therapy (8.5Gy × 2) for patients with symptomatic non-small cell lung cancer

✍ C.K Cross; S Berman; L Buswell; B Johnson; E Baldini 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 61 KB